Editor selected abstracts and commentaries
- New Prostate Cancer Screening Guidelines Could Detect Cancer Early, Save Lives
- Bladder cancer recurrence surveillance by urine metabolomics analysis.
- The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
- Narrative medicine in metastatic prostate cancer reveals ways to improve patient awareness & quality of care.
- Comparison of 3D and 2D gamma passing rate criteria for detection sensitivity to IMRT delivery errors.
Searchable data base of currently enrolling clinical trials
Recent data from conferences worldwide
- ASCO 2018: Measurable Immunologic Changes and Improved Clinical Activity in mRCC with Nivolumab + Bevacizumab or Nivolumab + Ipilimumab
- ASCO 2018: Pembrolizumab plus Enzalutamide in mCRPC: Extended Follow Up
- ASCO 2018: Enzalutamide Plus CC-115 in Men with mCRPC: A Phase 1b Prostate Cancer Clinical Trials Consortium Study
Print publications focusing on urological cancer treatments through original commentary & articles